Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 1998, p. 818-820, Vol. 42, No. 4
Laboratoire de Parasitologie,
Received 18 August 1997/Returned for modification 31 October
1997/Accepted 27 January 1998
The susceptibilities of three bovine and two human Babesia
divergens isolates to antimicrobial agents were evaluated in
vitro by a tritiated hypoxanthine incorporation assay. The MICs at
which 50% of isolates are inhibited (MIC50s) for
mefloquine (chlorhydrate), chloroquine (sulfate), quinine
(chlorhydrate), clindamycin (phosphate), pentamidine (isethionate),
phenamidine (isethionate) plus oxomemazine (chlorhydrate), lincomycin
(chlorhydrate monohydrate), and imidocarb (dipropionate) were
determined. Except for imidocarb, the MIC50s observed for
the different isolates were close. Imidocarb and the combination of
phenamidine plus oxomemazine exhibited the highest in vitro activity,
while antimalarial agents such as mefloquine, choroquine, and quinine
were inactive. Other drugs had intermediate activities. The data
support further in vitro evaluation of antimicrobial agents active
against B. divergens for the improvement of therapeutic strategies.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
In Vitro Evaluation of Drug Susceptibilities of
Babesia divergens Isolates
*
Corresponding author. Mailing address: Laboratoire de
Parasitologie, Hôpital Charles Nicolle, 1, rue de Germont, 76031 Rouen, France. Phone: (33) 2 32-88-80-15. Fax: (33) 2 32-88-80-17. E-mail: philippe.Brasseur{at}wanadoo.fr.
Antimicrobial Agents and Chemotherapy, April 1998, p. 818-820, Vol. 42, No. 4
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»